# v3.17

## Related releases

## Data changes
Gene:
FBXW2 Gene Added
MYH11 Gene Added
NUP214 Gene Added
PUM1 Gene Added
XPO1 Gene Summary Updated

Alteration:
ABL1 NUP214-ABL1 Fusion Added
BCL10 R58Q Added
BCL10 E140* Added
BRAF V600E, Mutation Effect Description Updated
BRCA1 R1753K Added
BRCA2 Q2829R Name Changed
	 New: Q2829R
	 Old: N2829R
BRCA2 Q2829R, Mutation Effect Description Updated
EGFR K860I Added
FBXW2 S84C Added
FBXW2 E269K Added
FBXW2 G258W Added
FBXW2 D30Y Added
MYH11 Gene Type Updated
MYH11 K1256del Added
MYH11 R669C Added
MYH11 R669H Added
NUP214 Gene Type Updated
POLE S297Y Name Changed
	 New: S297Y
	 Old: S279Y
POLE P436R, Oncogenicity Updated
	 New: Likely
	 Old: Inconclusive
POLE M444K Added
POLE D368Y Added
POLE F367V Added
POLE S459Y Added
POLE M295R, Oncogenicity Updated
TP53 L344P, Mutation Effect Description Updated
TP53 R337C, Mutation Effect Description Updated
TP53 L330H, Mutation Effect Description Updated
TP53 L330P, Mutation Effect Description Updated
TP53 L330R, Mutation Effect Description Updated
TP53 R337P, Mutation Effect Description Updated
TP53 F341C, Mutation Effect Description Updated
TP53 R342P, Mutation Effect Description Updated
TP53 L344R, Mutation Effect Description Updated
TP53 A347T, Mutation Effect Description Updated
TP53 R337H, Mutation Effect Description Updated
TP53 R337L, Mutation Effect Description Updated
TP53 F338I, Mutation Effect Description Updated
TP53 L348S, Mutation Effect Description Updated
TP53 P47S, Mutation Effect Description Updated
TP53 F134Y, Oncogenicity Updated
	 New: Inconclusive
	 Old: Likely
TP53 P152L, Mutation Effect Description Updated
TP53 R158H, Mutation Effect Description Updated
TP53 Y163C, Mutation Effect Description Updated
TP53 H193P, Mutation Effect Description Updated
TP53 C229R, Mutation Effect Description Updated
TP53 P219S, Mutation Effect Description Updated
TP53 N235D, Mutation Effect Description Updated
TP53 R248W, Mutation Effect Description Updated
TP53 I254T, Mutation Effect Description Updated
TP53 E285V, Mutation Effect Description Updated
TP53 R175L, Mutation Effect Description Updated
TP53 R175C, Oncogenicity Updated
TP53 K291E, Mutation Effect Description Updated
TP53 R267Q, Mutation Effect Description Updated
TP53 R273H, Mutation Effect Description Updated
TP53 R273G, Mutation Effect Description Updated
TP53 R213Q, Mutation Effect Description Updated
TP53 G245C, Oncogenicity Updated
TP53 H179Y, Mutation Effect Description Updated
TP53 H179L, Mutation Effect Description Updated
TP53 H179Q, Mutation Effect Description Updated
TP53 H179N, Mutation Effect Description Updated
TP53 H193R, Mutation Effect Description Updated
TP53 K291E, Oncogenicity Updated
	 New: Likely Neutral
TP53 K292T, Oncogenicity Updated
TP53 Q144R, Oncogenicity Updated
TP53 R290G, Oncogenicity Updated
TP53 R282Q, Mutation Effect Description Updated
TP53 R158L, Mutation Effect Updated
	 New: Likely Loss-of-function
	 Old: Loss-of-function
XPO1 R749Q Added

Evidence:
BRAF V600, Langerhans Cell Histiocytosis, Vemurafenib, Dabrafenib  Updated
CCNE1 Amplification, All Solid Tumors Added
FGFR2 Fusions, Cholangiocarcinoma, Tumor Type Summary Updated
FGFR2 Fusions, Cholangiocarcinoma, Futibatinib 1 Added
FGFR2 Fusions, Cholangiocarcinoma, Futibatinib 3A Deleted
FGFR2 Fusions, Cholangiocarcinoma, Futibatinib  Updated
KRAS G12D, All Solid Tumors Added
MET Amplification, Non-Small Cell Lung Cancer, Telisotuzumab Vedotin 3A Added
MET Amplification, Non-Small Cell Lung Cancer, Telisotuzumab Vedotin  Updated
PIK3CA Oncogenic Mutations, Breast Cancer Added
PIK3CA Oncogenic Mutations, All Solid Tumors Added
PIK3CA H1047R, Breast Cancer Added
PIK3CA H1047R, All Solid Tumors {excluding Colorectal Cancer} Added
PIK3CA H1047R, Breast Cancer, Tumor Type Summary Updated
RET Fusions, All Solid Tumors {excluding Non-Small Cell Lung Cancer, Thyroid Cancer} Added
RET Fusions, All Solid Tumors {excluding Non-Small Cell Lung Cancer, Thyroid Cancer}, Selpercatinib  Updated
TP53 Y220C, All Solid Tumors Added

